Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin in Children With Cerebral Palsy
NCT03710343Phase 2Completed
- Sponsor
- Holland Bloorview Kids Rehabilitation Hospital
- Start
- Nov 2023
- Primary completion
- Apr 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of liquid metformin (Aspargo Labs) in cerebral palsy (CP), sponsored by Holland Bloorview Kids Rehabilitation Hospital. Primary endpoints: First indicator of feasibility at 1.25 years, Second indicator of feasibility at 1.25 years and 3 more. Started Nov 2023; status: completed.
02
Drugs
liquid metformin (Aspargo Labs)
03
Conditions
cerebral palsy (CP)
Beyond the preview
Go deeper on NCT03710343.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03710343.